The Discrepant Dementia Workup
Mr. Adeyemi is a 74-year-old retired teacher referred to you for cognitive assessment. His daughter reports 18 months of repeating questions and one episode of getting lost driving a familiar route. MoCA score is 21/30, with points lost on delayed recall (2/5) and executive sequencing. He has 14 years of formal education and completed a university degree. His PHQ-9 is 12, and he has had two hospitalizations for major depression, most recently four years ago. He takes amitriptyline 50 mg nightly for insomnia and has done so for 20 years. His TSH, B12, and basic metabolic panel are normal. His daughter asks whether he has Alzheimer's disease and whether he should stop driving.
1. Interpret the MoCA score and identify at least three alternative explanations that must be ruled out before attributing the findings to a neurodegenerative process.
Read the worked answer
A raw MoCA of 21/30 falls below the conventional 26 cutoff, and with 14 years of education the education adjustment does not rescue the score; the pattern of impaired delayed recall plus executive sequencing is consistent with, but not diagnostic of, a cortical dementing illness. The score alone cannot establish etiology. Three plausible contributors must be addressed. First, depression: a PHQ-9 of 12 with prior hospitalizations raises pseudodementia or depression-related cognitive impairment; mood should be treated and cognition re-tested rather than assuming irreversible decline. Second, anticholinergic burden: amitriptyline 50 mg nightly for 20 years is a strongly anticholinergic agent and a recognized cause of reversible attentional and memory impairment in older adults; a supervised taper and re-assessment is warranted. Third, functional and informant data: the daughter's report of getting lost is more diagnostically weighty than the score, but a structured functional history and a validated informant measure are needed to distinguish mild cognitive impairment from dementia. Normal TSH, B12, and metabolic panel reduce but do not eliminate reversible causes; medication review, sleep, hearing, and vision also matter. The defensible conclusion is 'cognitive impairment of undetermined etiology, pending mood treatment and medication optimization,' not a diagnosis of Alzheimer's disease.
2. The daughter asks directly: 'Does he have Alzheimer's, and should he stop driving?' Draft your response and justify the clinical and ethical reasoning behind it.
Read the worked answer
The response should be honest about uncertainty, avoid premature diagnostic labeling, and address safety concretely. A workable structure: (1) name what is known - testing shows memory and thinking difficulties beyond what is expected for his age, and those difficulties are real and worth taking seriously; (2) name what is not known - the current picture could reflect depression and his long-standing sleep medication, and the appropriate next step is treating those and re-testing in roughly three to six months before concluding a neurodegenerative cause; (3) commit to a plan and a review date rather than leaving the family in limbo. On driving, do not issue a blanket prohibition based on a test score, but do not dismiss the concern. The episode of getting lost on a familiar route is a meaningful red flag. Recommend a practical safety plan: avoid night and long-distance driving, have a passenger on unfamiliar routes, and arrange a formal driving evaluation or occupational therapy assessment. Check jurisdiction-specific reporting duties; many regulators require reporting of conditions affecting fitness to drive, and this should be disclosed to the patient transparently. Document the conversation, the advice given, and the family's response.
3. Eight weeks later, after a slow taper of amitriptyline and behavioral activation for depression, his PHQ-9 is 4 and MoCA is 24/30, still losing points on delayed recall. What is your revised formulation and next step?
Read the worked answer
The improvement from 21 to 24 and the mood response confirm that depression and anticholinergic load were material contributors, which vindicates the decision not to diagnose prematurely. However, a residual deficit on delayed recall persists despite treated mood and reduced medication burden. This pattern supports a formulation of mild cognitive impairment - objective impairment with largely preserved function - rather than dementia, but the informant-reported getting-lost episode means functional status must be re-examined carefully; if instrumental activities are compromised, a dementia-level formulation becomes more defensible. Next steps: repeat a structured functional interview with the daughter, consider brief repeat cognitive testing in six to twelve months to establish trajectory, and pursue etiologic workup only insofar as it changes management. Document the revised formulation, the reasoning for the change, and the shared decision about monitoring interval. Avoid anchoring on the initial Alzheimer's framing; the data now argue against a confident neurodegenerative diagnosis.